These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21847480)

  • 1. Targeting of anionic membrane species by lanthanide(III) complexes: towards improved MRI contrast agents for apoptosis.
    Surman AJ; Kenny GD; Kumar DK; Bell JD; Casey DR; Vilar R
    Chem Commun (Camb); 2011 Oct; 47(37):10245-7. PubMed ID: 21847480
    [No Abstract]   [Full Text] [Related]  

  • 2. Tunable imaging of cells labeled with MRI-PARACEST agents.
    Aime S; Carrera C; Delli Castelli D; Geninatti Crich S; Terreno E
    Angew Chem Int Ed Engl; 2005 Mar; 44(12):1813-5. PubMed ID: 15723362
    [No Abstract]   [Full Text] [Related]  

  • 3. Lanthanides in magnetic resonance imaging.
    Bottrill M; Kwok L; Long NJ
    Chem Soc Rev; 2006 Jun; 35(6):557-71. PubMed ID: 16729149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paramagnetic liposomes as innovative contrast agents for magnetic resonance (MR) molecular imaging applications.
    Terreno E; Delli Castelli D; Cabella C; Dastrù W; Sanino A; Stancanello J; Tei L; Aime S
    Chem Biodivers; 2008 Oct; 5(10):1901-1912. PubMed ID: 18972531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paramagnetic lanthanide complexes as PARACEST agents for medical imaging.
    Woods M; Woessner DE; Sherry AD
    Chem Soc Rev; 2006 Jun; 35(6):500-11. PubMed ID: 16729144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From spherical to osmotically shrunken paramagnetic liposomes: an improved generation of LIPOCEST MRI agents with highly shifted water protons.
    Terreno E; Cabella C; Carrera C; Delli Castelli D; Mazzon R; Rollet S; Stancanello J; Visigalli M; Aime S
    Angew Chem Int Ed Engl; 2007; 46(6):966-8. PubMed ID: 17167807
    [No Abstract]   [Full Text] [Related]  

  • 7. Towards polymetallic lanthanide complexes as dual contrast agents for magnetic resonance and optical imaging.
    Debroye E; Parac-Vogt TN
    Chem Soc Rev; 2014 Dec; 43(23):8178-92. PubMed ID: 25211043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging.
    Chauvin T; Torres S; Rosseto R; Kotek J; Badet B; Durand P; Tóth E
    Chemistry; 2012 Jan; 18(5):1408-18. PubMed ID: 22213022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective imaging of damaged bone structure (microcracks) using a targeting supramolecular Eu(III) complex as a lanthanide luminescent contrast agent.
    McMahon B; Mauer P; McCoy CP; Lee TC; Gunnlaugsson T
    J Am Chem Soc; 2009 Dec; 131(48):17542-3. PubMed ID: 19916488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards an Improved Design of MRI Contrast Agents: Synthesis and Relaxometric Characterisation of Gd-HPDO3A Analogues.
    Tear LR; Carrera C; Gianolio E; Aime S
    Chemistry; 2020 May; 26(27):6056-6063. PubMed ID: 32133687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ParaCEST MRI contrast agents capable of derivatization via"click" chemistry.
    Milne M; Chicas K; Li A; Bartha R; Hudson RH
    Org Biomol Chem; 2012 Jan; 10(2):287-92. PubMed ID: 22069041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The population of SAP and TSAP isomers in cyclen-based lanthanide(III) chelates is substantially affected by solvent.
    Miller KJ; Saherwala AA; Webber BC; Wu Y; Sherry AD; Woods M
    Inorg Chem; 2010 Oct; 49(19):8662-4. PubMed ID: 20812752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pH-reporter MRI contrast agents.
    Aime S; Delli Castelli D; Terreno E
    Angew Chem Int Ed Engl; 2002 Nov; 41(22):4334-6. PubMed ID: 12434381
    [No Abstract]   [Full Text] [Related]  

  • 14. De novo design of Ln(III) coiled coils for imaging applications.
    Berwick MR; Lewis DJ; Jones AW; Parslow RA; Dafforn TR; Cooper HJ; Wilkie J; Pikramenou Z; Britton MM; Peacock AF
    J Am Chem Soc; 2014 Jan; 136(4):1166-9. PubMed ID: 24405157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water soluble, cyclometalated Pt(ii)-Ln(iii) conjugates towards novel bimodal imaging agents.
    Stacey OJ; Amoroso AJ; Platts JA; Horton PN; Coles SJ; Lloyd D; Williams CF; Hayes AJ; Dunsford JJ; Pope SJ
    Chem Commun (Camb); 2015 Aug; 51(61):12305-8. PubMed ID: 26137914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-resonance low B1 pulses for imaging of the effects of PARACEST agents.
    Vinogradov E; Zhang S; Lubag A; Balschi JA; Sherry AD; Lenkinski RE
    J Magn Reson; 2005 Sep; 176(1):54-63. PubMed ID: 15979362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of targeting ligands in medicinal inorganic chemistry.
    Storr T; Thompson KH; Orvig C
    Chem Soc Rev; 2006 Jun; 35(6):534-44. PubMed ID: 16729147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lanthanide Complexes in Molecular Magnetic Resonance Imaging and Theranostics.
    Lacerda S; Tóth É
    ChemMedChem; 2017 Jun; 12(12):883-894. PubMed ID: 28470934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. αvβ3-Integrin-targeting lanthanide complex: synthesis and evaluation as a tumor-homing luminescent probe.
    Ito T; Inoue M; Akamatsu K; Kusaka E; Tanabe K; Nishimoto S
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3515-8. PubMed ID: 21600766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prototypes of Lanthanide(III) Agents Responsive to Enzymatic Activities in Three Complementary Imaging Modalities: Visible/Near-Infrared Luminescence, PARACEST-, and T1-MRI.
    He J; Bonnet CS; Eliseeva SV; Lacerda S; Chauvin T; Retailleau P; Szeremeta F; Badet B; Petoud S; Tóth É; Durand P
    J Am Chem Soc; 2016 Mar; 138(9):2913-6. PubMed ID: 26727374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.